Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-Phenylheme
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
2-Phenylheme is an experimental small molecule compound with the chemical formula C40H36FeN4O4 and a molecular weight of approximately 692.6 g/mol[1][2][3]. It is structurally related to heme, featuring a phenyl group substitution. The primary known mechanism of action involves interaction with heme oxygenase 1 in humans, though detailed pharmacological properties and clinical indications are not available[1]. The compound has been studied for its biochemical properties but does not have established therapeutic uses or approved medical indications.
- Other names
- 2-PHENYLHEMESCHEMBL4327264SCHEMBL-4327264SCHEMBL 4327264
02
Targets
HMOX1 (Heme oxygenase 1)
Beyond the preview
Go deeper on 2-Phenylheme.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-Phenylheme.